KemPharm competitorsClear all

KemPharm's top competitors include Atopix, Idera Pharmaceuticals, Akebia Therapeutics and Biothera.
KemPharm
KemPharm
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
Atopix
Atopix
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK
Idera Pharmaceuticals
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Biothera
Biothera
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
Founding Date
Founding Date
2006
Founding Date
2012
Founding Date
1989
Founding Date
2007
Founding Date
1997
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Kissimmee, US HQ
Blacksburg, US
Coralville, US
Coralville, US
Locations
Milton, GB HQ
Locations
Cambridge, US HQ
Exton, US
Locations
Cambridge, US HQ
Locations
Roseville, US HQ
Employees
Employees
333% increase
Employees
N/A
Employees
3642% decrease
Employees
324187% increase
Employees
452% decrease
Valuation ($)
Valuation ($)
51.4 m
Valuation ($)
N/A
Valuation ($)
78.8 m
Valuation ($)
355.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
144
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.2 k
Twitter followers
340
Alexa Website Rank
Alexa Website Rank
396119
Alexa Website Rank
N/A
Alexa Website Rank
386069
Alexa Website Rank
340831
Alexa Website Rank
376463
Employee Rating
Employee Rating
4
Employee Rating
N/A
Employee Rating
4.3
Employee Rating
4.6
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
$12.8m (FY, 2019)
Revenue (est.)
£453.4k (FY, 2017)
Revenue (est.)
$1.4m (FY, 2019)
Revenue (est.)
$335m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$10m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$108.9m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
$2.8m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$226.1m (FY, 2019)
Gross profit
N/A
Net income
Net income
($24.5m) (FY, 2019)
Net income
£592.1k (FY, 2017)
Net income
($56.5m) (FY, 2019)
Net income
($279.7m) (FY, 2019)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 5.1m (about 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 1.6m (almost 6 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 5.1m
Total funding raised
$ 13.8m
Total funding raised
N/A
Total funding raised
$ 5.1m
For sources of this data, please see the company profile

View company profiles

Atopix
HQ
Milton, GB

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK

View company
Idera Pharmaceuticals
HQ
Cambridge, US
Employees
36↓ 42% decrease

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company
Biothera
HQ
Roseville, US
Employees
45↓ 2% decrease

Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.

View company